Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder.
Kaplan
Gary B
GB
McRoberts
Robert Lowell
RL
Smokler
Herbert J
HJ
D000437:Alcoholism / Q000534:rehabilitation*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001418:Baclofen / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000534:rehabilitation*; D019970:Cocaine-Related Disorders / Q000534:rehabilitation*; D015897:Comorbidity; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use; D005500:Follow-Up Studies; D018755:GABA Agonists / Q000627:therapeutic use*; D006801:Humans; D008134:Long-Term Care; D008297:Male; D002189:Marijuana Abuse / Q000534:rehabilitation; D008875:Middle Aged; D018967:Risperidone / Q000627:therapeutic use; D055502:Secondary Prevention
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D018755:GABA Agonists; D005473:Fluoxetine; D001418:Baclofen; D018967:Risperidone